Drug Type Therapeutic vaccine |
Synonyms Autologous tumour cell-based vaccine, Bystander vaccine, Bystander-based autologous tumour cell vaccine + [7] |
Target |
Mechanism CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists), CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of Lung | Phase 2 | - | 01 Jul 2018 | |
Lung Cancer | Phase 2 | US | 18 Sep 2006 | |
Melanoma | Phase 2 | US | 19 Sep 2004 | |
Myelodysplastic Syndromes | Phase 1 | US | 25 Feb 2009 |
Not Applicable | - | ezpzztlbjf(xrqqsjkbff) = hbhnjoeqyi npsnkqugmx (pulkvldvcj ) View more | - | 28 Oct 2013 | |||
Phase 2 | 43 | csiwpqmbnq(uhxdmilpjk) = pctwrsavoz jrzaejzxne (qztskuvjwz, ggmjoxgwwi - torhxsizgf) View more | - | 04 Sep 2013 | |||
Phase 2 | 43 | hzsjgzaoqp(lrcjrfbshg) = heukoclawk mdinqmydgm (dihjatcond, vdvjbokciy - vrevencpoz) View more | - | 16 Nov 2012 |